rs150157112
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024884.3(L2HGDH):c.1177A>G(p.Thr393Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,611,704 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024884.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
L2HGDH | NM_024884.3 | c.1177A>G | p.Thr393Ala | missense_variant | 9/10 | ENST00000267436.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
L2HGDH | ENST00000267436.9 | c.1177A>G | p.Thr393Ala | missense_variant | 9/10 | 1 | NM_024884.3 | P1 | |
L2HGDH | ENST00000261699.8 | c.1177A>G | p.Thr393Ala | missense_variant | 9/10 | 1 | |||
L2HGDH | ENST00000421284.7 | c.1177A>G | p.Thr393Ala | missense_variant | 9/11 | 2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000223 AC: 34AN: 152204Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000235 AC: 59AN: 251240Hom.: 1 AF XY: 0.000221 AC XY: 30AN XY: 135820
GnomAD4 exome AF: 0.000318 AC: 464AN: 1459382Hom.: 2 Cov.: 30 AF XY: 0.000325 AC XY: 236AN XY: 726234
GnomAD4 genome ? AF: 0.000217 AC: 33AN: 152322Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74484
ClinVar
Submissions by phenotype
L-2-hydroxyglutaric aciduria Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 27, 2022 | This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 393 of the L2HGDH protein (p.Thr393Ala). This variant is present in population databases (rs150157112, gnomAD 0.05%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with L2HGDH-related conditions. ClinVar contains an entry for this variant (Variation ID: 435690). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt L2HGDH protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 30, 2020 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 14, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.1177A>G (p.T393A) alteration is located in exon 9 (coding exon 9) of the L2HGDH gene. This alteration results from a A to G substitution at nucleotide position 1177, causing the threonine (T) at amino acid position 393 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at